Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience.
Dario RoccatelloRoberta FenoglioCarla NarettoSimone BaldovinoSavinio SciasciaMichela FerroDaniela RossiPublished in: Journal of clinical medicine (2020)
Our data show that monotherapy with DARA had significant clinical efficacy in pretreated/naïve patients with severe AL amyloidosis and biopsy-proven renal involvement.